Nuvalent
Nuvalent is creating precisely targeted therapies for patients with cancer.
2
Funding Rounds
$185.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| An** Pr******** | - | - | |
| Em*** Dr***** Co**** | - | - | - |
| Ma***** D. Sh*** | - | - | - |
| Ca***** Wh***** | - | - | - |
| Jo**** Pe******* | - | - | - |
| An**** Ha** | - | - | - |
| Ga** Gi******* | - | - | - |
| Sa*** Sr******** | - | - | - |
| Ja*** Po**** (e************ | - | - |
Funding series
Funding Series Analysis
The company Nuvalent has raised a total of $185m in funding over 2 rounds.
Key Insights:
- Nuvalent Series B round, May 2021: $135m
- Nuvalent , January 2021: $50m
Nuvalent Series B round, May 2021
$135m
Nuvalent , January 2021
$50m
Industries
Nuvalent is active in the following industries:
- Technology
- Biotechnology
- Engineering
- Biomedical engineering
- Biology